ABSTRACT
Objective To determine whether handheld widefield optical coherence tomography (OCT) can be used to document retinopathy of prematurity (ROP) stage while using scleral depression to improve peripheral views.
Design Prospective observational study
Participants Consecutive neonates admitted to the neonatal intensive care unit (NICU) in a single academic medical center who also met criteria for ROP screening and consented for research imaging.
Methods Scleral depression was combined with widefield OCT using an investigational 400-kHz, 55-degree field of view handheld OCT during ROP screening from October 28, 2020 to March 03, 2021.
Main Outcome Measures Acquisition of en face and B-scan imaging of the peripheral retina to objectively assess early vitreoretinal pathology, including the demarcation between vascularized and anterior avascular retina, the presence of early ridge formation, and small neovascular tufts.
Results Various stages of ROP were detected using a rapid acquisition OCT system. In one neonate, serial OCT imaging over a five-week period demonstrated accumulation of neovascular tufts with progression to stage 3 ROP with extraretinal fibrovascular proliferation along the ridge. Videography of this technique is included in this report for instructional purposes.
Conclusions Serial examinations using widefield OCT and scleral depression may improve detection and documentation of ROP disease progression. Earlier detection of ROP-related proliferation may prevent vitreoretinal traction, retinal detachment, and blindness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants R01 EY19474, R01 EY031331, R21 EY031883, and P30 EY10572 from the National Institutes of Health (Bethesda, MD), and by unrestricted departmental funding and a Career Development Award (JPC) and a Career Advancement Award (YJ) from Research to Prevent Blindness (New York, NY)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
the Institutional Review Board/Ethics Committee of OHSU gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial Support: This work was supported by grants R01 EY19474, R01 EY031331, R21 EY031883, and P30 EY10572 from the National Institutes of Health (Bethesda, MD), and by unrestricted departmental funding and a Career Development Award (JPC) and a Career Advancement Award (YJ) from Research to Prevent Blindness (New York, NY).
Financial Disclosures: J. Peter Campbell receives research support from Genentech and is a consultant to Boston AI labs. Yifan Jian has financial interests in Seymour Vision. Oregon Health & Science University (OHSU) and Yali Jia have a significant financial interest in Optos, Inc. OHSU, Yali Jia, and David Huang have a significant financial interest in Optovue, Inc. These potential conflicts of interest have been reviewed and managed by OHSU. Other authors declare that there are no conflicts of interest related to this article.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
